Autor: |
Ga I. Ban, Vijitha Puviindran, Yu Xiang, Puvi Nadesan, Jackie Tang, Jianhong Ou, Nicholas Guardino, Makoto Nakagawa, MaKenna Browne, Asjah Wallace, Koji Ishikawa, Eijiro Shimada, John T. Martin, Yarui Diao, David G. Kirsch, Benjamin A. Alman |
Jazyk: |
angličtina |
Rok vydání: |
2024 |
Předmět: |
|
Zdroj: |
iScience, Vol 27, Iss 7, Pp 110187- (2024) |
Druh dokumentu: |
article |
ISSN: |
2589-0042 |
DOI: |
10.1016/j.isci.2024.110187 |
Popis: |
Summary: Intratumoral heterogeneity is common in cancer, particularly in sarcomas like undifferentiated pleomorphic sarcoma (UPS), where individual cells demonstrate a high degree of cytogenic diversity. Previous studies showed that a small subset of cells within UPS, known as the metastatic clone (MC), as responsible for metastasis. Using a CRISPR-based genomic screen in-vivo, we identified the COMPASS complex member Setd1a as a key regulator maintaining the metastatic phenotype of the MC in murine UPS. Depletion of Setd1a inhibited metastasis development in the MC. Transcriptome and chromatin sequencing revealed COMPASS complex target genes in UPS, such as Cxcl10, downregulated in the MC. Deleting Cxcl10 in non-MC cells increased their metastatic potential. Treating mice with human UPS xenografts with a COMPASS complex inhibitor suppressed metastasis without affecting tumor growth in the primary tumor. Our data identified an epigenetic program in a subpopulation of sarcoma cells that maintains metastatic potential. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|